Advertisement

National and regional assessment of the antibacterial soap market: A step toward determining the impact of prevalent antibacterial soaps

  • Author Footnotes
    a From the Department of Medicine, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston
    Eli N. Perencevich
    Correspondence
    Reprint requests: Eli N. Perencevich, MD, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, One Deaconess Road, Kennedy 6th floor, Boston, MA 02215.
    Footnotes
    a From the Department of Medicine, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston
    Affiliations
    Boston, Massachusetts, and Baltimore, Maryland
    Search for articles by this author
  • Author Footnotes
    a From the Department of Medicine, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston
    Michael T. Wong
    Footnotes
    a From the Department of Medicine, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston
    Affiliations
    Boston, Massachusetts, and Baltimore, Maryland
    Search for articles by this author
  • Author Footnotes
    b From the Department of Epidemiology and Preventative Medicine, Division of Healthcare Outcomes Research, University of Maryland, Baltimore
    Anthony D. Harris
    Footnotes
    b From the Department of Epidemiology and Preventative Medicine, Division of Healthcare Outcomes Research, University of Maryland, Baltimore
    Affiliations
    Boston, Massachusetts, and Baltimore, Maryland
    Search for articles by this author
  • Author Footnotes
    a From the Department of Medicine, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston
    b From the Department of Epidemiology and Preventative Medicine, Division of Healthcare Outcomes Research, University of Maryland, Baltimore
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Background: Consumer antibacterial soaps contain triclosan or triclocarban. No scientific data have been published to suggest that the use of antibacterial agents in household products prevents infection, and triclosan resistance mechanisms have recently been identified. Little data are available regarding the prevalence of antibacterial agents contained in consumer soaps.
      Methods: In a physician-performed survey of 23 stores in 10 states from December 1999 to April 2000, investigators determined the number of national brand liquid and bar soaps and percent of each containing antibacterial agents sold at national chain, regional grocery, and Internet stores.
      Results: Antibacterial agents were present in 76% of liquid soaps and 29% of bar soaps available nationally. There were no differences found between national, regional, and Internet stores.
      Conclusion: Overall, 45% of surveyed soaps contain antibacterial agents. With limited documented benefits and experimental laboratory evidence suggesting possible adverse effects on the emergence of antimicrobial resistance, consumer antibacterial use of this magnitude should be questioned.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Tierno Jr, P.M.
        Efficacy of triclosan [letter].
        Am J Infect Control. 1999; 27: 71-72
        • Jones R.D.
        • Jampani H.B.
        • Newman J.L.
        • Lee A.S.
        Triclosan: a review of effectiveness and safety in health care settings.
        Am J Infect Control. 2000; 28: 184-196
        • McDonnell G.
        • Russell A.D.
        Antiseptics and disinfectants: activity, action, and resistance.
        Clin Microbiol Rev. 1999; 12: 147-779
        • Slater F.M.
        Efficacy of triclosan [letter].
        Am J Infect Control. 1999; 27: 72-73
        • McMurry L.M.
        • Oethinger M.
        • Levy S.B.
        Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli.
        FEMS Microbiol Lett. 1998; 166: 305-309
        • McMurry L.M.
        • Oethinger M.
        • Levy S.B.
        Triclosan targets lipid synthesis [letter].
        Nature. 1998; 394: 531-532
        • McMurry L.M.
        • McDermott P.F.
        • Levy S.B.
        Genetic evidence that InhA of Mycobacterium smegrnatis is a target for triclosan.
        Antimicrob Agents Chemother. 1999; 43: 711-713
        • Schweizer H.P.
        Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems.
        Antimicrob Agents Chemother. 1998; 42: 394-398
        • Hoang T.T.
        • Schweizer H.P.
        Characterization of Pseudornonas aeruginosa enopl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone svnthesis.
        J Bacteriol. 1999; 181: 5489-5497
        • Heath R.J.
        • Li J.
        • Roland G.E.
        • Rock C.O.
        Inhibition of the Staphylococcus aureus NADPH-dependent enovl-acyl carrier protein reductase by triclosan and hexachlorophene.
        J Biol Chem. 2000; 275: 4654-4659
        • Levy S.B.
        • McMurry L.M.
        Efficacy of triclosan [letter].
        Am J Infect Control. 1999; 27: 73-74
        • Zafar A.B.
        • Gaydos L.A.
        • Furlong W.B.
        • Nguyen M.H.
        • Mennonna P.A.
        Effectiveness of infection control program in controlling nosocomial Clostridium difficile.
        Am J Infect Control. 1998; 26: 588-593
        • Irish D.
        • Eltringham I.
        • Teall A.
        • Pickett H.
        • Farelly H.
        • Reith S.
        • et al.
        Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin.
        J Hosp Infect. 1998; 39: 19-26
        • Heath R.J.
        • Rubin J.R.
        • Holland D.R.
        • Zhang E.
        • Snow M.E.
        • Rock C.O.
        Mechanism of triclosan inhibition of bacterial fatty acid synthesis.
        J Biol Chem. 1999; 274: 11110-11114
        • Levy C.W.
        • Roujeinikova A.
        • Sedelnikova S.
        • Baker P.J.
        • Stuitje A.R.
        • Slabas A.R.
        • et al.
        Molecular basis of triclosan activity [letter].
        Nature. 1999; 398: 383-384
        • Heath R.J.
        • Yu Y.T.
        • Shapiro M.A.
        • Olson E.
        • Rock C.O.
        Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis.
        J Biol Chem. 1998; 273: 30316-30320